메뉴 건너뛰기




Volumn 8, Issue 7, 2013, Pages 1067-1085

The lab oddity prevails: Discovery of Pan-CDK inhibitor (R)-S-Cyclopropyl-S-(4-{[4-{[(1R,2R)-2-hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide (BAY1000394) for the treatment of cancer

Author keywords

Antitumor agents; Biological activity; CDK; Medicinal chemistry; Sulfoximines

Indexed keywords

ANTINEOPLASTIC AGENT; BAY 1000394; BUTHIONINE SULFOXIMINE; CARBONATE DEHYDRATASE; CYCLOPROPYL[4 [[4[[[(1 ,2 ) 2 HYDROXY 1 METHYLPROPYL]OXY] 5 (TRIFLUOROMETHYL)PYRIMIDIN 2 YL]AMINO]PHENYL]SULFOXIMIDE; SULFONAMIDE; UNCLASSIFIED DRUG; ZK 304709;

EID: 84879785697     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201300096     Document Type: Article
Times cited : (155)

References (50)
  • 35
    • 84879785813 scopus 로고    scopus 로고
    • This method also gave very good results in other imination reactions, but was later abandoned due to safety concerns.
    • This method also gave very good results in other imination reactions, but was later abandoned due to safety concerns.
  • 41
    • 84904274827 scopus 로고    scopus 로고
    •  
  • 43
    • 84879784695 scopus 로고    scopus 로고
    • Bayer Schering Pharma AG), DE 102010014427
    • U. Luecking, G. Siemeister, A. Wengner, (Bayer Schering Pharma AG), DE 102010014427, 2011.
    • (2011)
    • Luecking, U.1    Siemeister, G.2    Wengner, A.3
  • 46
    • 84879787279 scopus 로고    scopus 로고
    • SYBYL 6.7, Tripos Inc., 1699 S. Hanley Road, Suite 303, St.Louis, MO 63144-2913 (USA), 2000.
    • SYBYL 6.7, Tripos Inc., 1699 S. Hanley Road, Suite 303, St.Louis, MO 63144-2913 (USA), 2000.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.